Hasleton J - Search Results

1

Primary percutaneous coronary intervention in nonagenarians: is it worthwhile?

Meah MMN, Joseph T, Ding WY, Shaw M, Hasleton J, Palmer ND, Velavan P, Aggarwal SK. Meah MMN, et al. Among authors: hasleton j. BMC Cardiovasc Disord. 2021 Jan 13;21(1):30. doi: 10.1186/s12872-020-01833-2. BMC Cardiovasc Disord. 2021. PMID: 33435875 Free PMC article.

2

Complex Chronic Total Occlusion Revascularization - A Comparison of Biradial Versus Femoral Access.

Meah MN, Ding WY, Joseph T, Hasleton J, Shaw M, Palmer ND. Meah MN, et al. Among authors: hasleton j. J Invasive Cardiol. 2021 Jan;33(1):E52-E58. J Invasive Cardiol. 2021. PMID: 33385987 Free article.

3

Myocardial rupture and left ventricular pseudoaneurysm due to late STEMI presentation during the COVID-19 pandemic lockdown: a classical case report.

Banisauskaite A, Velavan P, Hasleton J, Mediratta N, Arzanauskaite M, Binukrishnan S. Banisauskaite A, et al. Among authors: hasleton j. Eur Heart J Case Rep. 2021 Jul 18;5(7):ytab253. doi: 10.1093/ehjcr/ytab253. eCollection 2021 Jul. Eur Heart J Case Rep. 2021. PMID: 34377907 Free PMC article.

4

Isolated Left Ventricular Hypoplasia in a Postpartum Patient.

Ding WY, Meah M, Rao A, Fairbairn T, Hasleton J. Ding WY, et al. Among authors: hasleton j. Can J Cardiol. 2016 Jun;32(6):829.e15-7. doi: 10.1016/j.cjca.2015.08.012. Epub 2015 Aug 20. Can J Cardiol. 2016. PMID: 26706664

5

Ventricular Hinge Point Fibrosis as a Pathological Marker of Hypertrophic Cardiomyopathy in the Absence of Significant Left Ventricular Hypertrophy?

Ding WY, Cooper RM, Hasleton J, McKay V, Modi S. Ding WY, et al. Among authors: hasleton j. Can J Cardiol. 2016 Dec;32(12):1577.e13-1577.e14. doi: 10.1016/j.cjca.2016.02.048. Epub 2016 Feb 17. Can J Cardiol. 2016. PMID: 27177834

6

Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial.

Ludman AJ, Yellon DM, Hasleton J, Ariti C, Babu GG, Boston-Griffiths E, Venugopal V, Walker M, Holdright D, Swanton H, Crake T, Brull D, Moon JC, Puranik R, Muthurangu V, Taylor A, Hausenloy DJ. Ludman AJ, et al. Among authors: hasleton j. Heart. 2011 Oct;97(19):1560-5. doi: 10.1136/hrt.2011.223867. Heart. 2011. PMID: 21900585 Clinical Trial.

7

Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance.

Flett AS, Hasleton J, Cook C, Hausenloy D, Quarta G, Ariti C, Muthurangu V, Moon JC. Flett AS, et al. Among authors: hasleton j. JACC Cardiovasc Imaging. 2011 Feb;4(2):150-6. doi: 10.1016/j.jcmg.2010.11.015. JACC Cardiovasc Imaging. 2011. PMID: 21329899 Free article.

8

Beta-blocker use in heart failure patients with airways disease.

Shaw SM, Hasleton J, Williams SG. Shaw SM, et al. Among authors: hasleton j. Clin Cardiol. 2009 Jul;32(7):393-6. doi: 10.1002/clc.20590. Clin Cardiol. 2009. PMID: 19609894 Free PMC article.

9

Computed tomography angiography planning identifies the target vessel for optimum infarct location and improves clinical outcome in alcohol septal ablation for hypertrophic obstructive cardiomyopathy.

Cooper RM, Binukrishnan SR, Shahzad A, Hasleton J, Sigwart U, Stables RH. Cooper RM, et al. Among authors: hasleton j. EuroIntervention. 2017 Apr 7;12(18):e2194-e2203. doi: 10.4244/EIJ-D-15-00159. EuroIntervention. 2017. PMID: 27890861 Free article.

10

Cardiac Computed Tomography to Identify and Guide Therapy of Intramural Hemorrhage in High-Risk Coronary Anatomy.

Jatti K, Maurovich-Horvat P, Hasleton J, Uddin M, Ruzsics B. Jatti K, et al. Among authors: hasleton j. JACC Case Rep. 2021 Jan 20;3(1):120-124. doi: 10.1016/j.jaccas.2020.11.014. eCollection 2021 Jan. JACC Case Rep. 2021. PMID: 34317483 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page